The U.S. Centers for Disease Control and Prevention (CDC) is leading a consortium of malaria partners aiming to eliminate indigenous cases of malaria on the island of Hispaniola by 2020. Hispaniola, which includes the countries of Haiti and the Dominican Republic, is the only remaining island in the Caribbean where malaria is endemic.

To help implement the CDC Foundation programs and activities supporting the Targeted Country Assistance portion of the 2022-2025 Partners’ Engagement Framework.

To conduct performance evaluations, including operational characteristics of malaria rapid diagnostic tests submitted for WHO for assessment under the WHO Prequalification of In Vitro Diagnostics submitted to WHO for assessment under the Emergency Use Listing.

To develop data that will contribute to an assessment of whether transgenic mosquitoes could be effectively and safely deployed to control natural populations of malaria vectors.